Terrance H. Gregg is Executive Chairman of the Board of Directors of Dexcom, Inc., first joining the Dexcom Board of Directors in 2005, and subsequently appointed as President and CEO in 2007, CEO in 2011, and Executive Chairman in 2015.
In 2002 he retired as President of Medtronic MiniMed, a diabetes management systems. He became President and Chief Operating Officer of MiniMed, Inc. in 1996 and was instrumental in Medtronic’s $3.4 billion acquisition of MiniMed in 2001. He also served in executive positions with Smith and Nephew and Allergan, Inc.
Mr. Gregg served as the 2003-2004 Chair of the Research Foundation Board of the American Diabetes Association. In 2010, Mr. Gregg and his wife were recognized by the Juvenile Diabetes Research Foundation (JDRF) with one of its highest honors, the 2010 Angel Award. Most recently, Mr. Gregg was honored as one of the San Diego regional finalists for the Ernst and Young Entrepreneur of the Year Award and named by MassDevice.com, one of 28 chief executives whom exemplify cutting-edge leadership and innovative thinking in the medical device industry, as its inaugural CEO Class. Mr. Gregg currently serves on several advisory boards, including the Scripps Translational Science Institute. Mr. Gregg received a Bachelor of Science degree from Colorado State University in 1971.